ACADIA PHARMACEUTICALS INC Logo

ACADIA PHARMACEUTICALS INC

Biopharmaceutical company developing medicines for CNS disorders and rare diseases.

ACAD | US

Overview

Corporate Details

ISIN(s):
US0042251084
LEI:
Country:
United States of America
Address:
12830 EL CAMINO REAL, 92130 SAN DIEGO

Description

ACADIA PHARMACEUTICALS INC. is a biopharmaceutical company focused on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases. The company's commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. Acadia is advancing a diverse clinical pipeline with mid- to late-stage programs targeting conditions such as Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside early-stage programs addressing other unmet patient needs. The company's mission is to provide innovative therapies and support to underserved patient communities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-19 19:00 English ZIP 8.5 KB
2025-11-19 19:00 English ZIP 8.4 KB
2025-11-14 09:16 English ZIP 9.9 KB
2025-11-12 19:00 English ZIP 7.2 KB
2025-11-10 18:59 English ZIP 7.2 KB
2025-11-05 19:47
10-Q
English ZIP 1.6 MB
2025-11-05 17:13
8-K
English ZIP 95.2 KB
2025-11-03 17:23
8-K
English ZIP 51.0 KB
2025-09-16 20:00 English ZIP 7.3 KB
2025-09-03 20:00 English ZIP 7.0 KB
2025-08-19 20:00 English ZIP 7.2 KB
2025-08-18 18:31 English ZIP 6.9 KB
2025-08-06 19:53
10-Q
English ZIP 2.7 MB
2025-08-06 18:18
8-K
English ZIP 96.3 KB
2025-06-10 18:06
8-K
English ZIP 53.4 KB

Automate Your Workflow. Get a real-time feed of all ACADIA PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ACADIA PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ACADIA PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA
Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.